Pregnancy rates among female participants in phase I and phase IIA AIDS vaccine clinical trials in Kenya

Citation:
Jaoko W, OGUTU H, WAKASIAKA S, MALOGO R, NDAMBUKI R, NYANGE J, OMOSA-MANYONYI G, FAST P, SCHMIDT C, VERLINDE C, SMITH C, Bhatt KM, Ndinya-Achola JO, Anzala O. "Pregnancy rates among female participants in phase I and phase IIA AIDS vaccine clinical trials in Kenya.". 2009.

Abstract:

Female participants in AIDS candidate vaccine clinical trials must agree to use effective contraception to be enrolled into the studies, and for a specified period after vaccination, since the candidate vaccines’ effects on the embryo or foetus are unknown.country settings. Effective female-controlled contraceptives, administered at the clinical trial site, may empower female participants to better control their fertility, leading to more complete clinical trial data.

UoN Websites Search